Trevi Therapeutics Aktie
4,05
USD
-0,10
USD
-2,41
%
4,05
USD
-0,10
USD
-2,41
%
Trevi Therapeutics Aktie Analyse
03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |